STAT+: Pharmalittle: U.S. speeds plan for pharmacies to give Covid-19 shots; European agency okays Moderna vaccine
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
Category: Pharma
STAT+: Pharmalittle: FDA warns against changing Covid-19 vaccine dosing; Moderna to increase vaccine production
Hello, everyone, and how are you today? We are doing just fine, thank you, as…
STAT+: The biotech scorecard for the first quarter: 17 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first…
STAT+: Pharma rings in the new year with 5% price hikes on hundreds of medicines
When it comes to prescription drug prices, what goes up often continues to go up…
STAT+: HHS rebukes drug makers for curtailing discounts to hospitals that serve low-income communities
After months of controversy, the Department of Health and Human Services issued a stern rebuke…
STAT+: Pharmalittle: U.S. considers giving half-doses of Moderna vaccine; Americans may not get AstraZeneca shot until April
Good morning, everyone, and nice to see you after an extended holiday break. We hope…
STAT+: Indian regulators are pushed to release Covid-19 vaccine trial protocol
As Indian regulators consider emergency approval of a Covid-19 vaccine from the Serum Institute of…
STAT+: 3 pharma trends to watch in 2021
To say this past year has been like no other is an understatement. But for…
STAT+: Pharmalittle: Feds sue Walmart over opioid prescriptions; U.S. buys more Pfizer vaccine doses
Good morning, everyone. Damian Garde here, filling in for Ed Silverman one last time as…
STAT+: Pharmalittle: EU clears Pfizer’s Covid-19 vaccine; Americans are increasingly willing to get the shot
Good morning, everyone. Damian Garde here, filling in for Ed Silverman once more in the…
STAT+: Pharmalittle: Moderna’s Covid-19 vaccine rolls out across the U.S.; FDA rejects Novartis cholesterol drug
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on this…
STAT-Harris Poll: Most Americans would support Biden issuing a mask mandate
Most Americans believe the Biden administration should mandate several steps — such as requiring people…
STAT+: Sacklers withdrew cash from Purdue over opioid lawsuit fears, documents show
In recent weeks, different members of the Sackler family that controls Purdue Pharma maintained they…
STAT+: World Health Organization says its Covid-19 vaccine program has secured 2 billion doses
After months of effort, a World Health Organization program has reached an agreement to obtain…
STAT+: Pharmalittle: FDA panel endorses Moderna Covid-19 vaccine; Sacklers dodge blame for opioid crisis at hearing
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Biogen to pay $22 million for illegally using charities to pay kickbacks to Medicare patients
Biogen (BIIG) has agreed to pay $22 million to resolve allegations that donations it paid…
Sackler family members deny responsibility for the opioid crisis in a rare public appearance
In a first-of-its-kind appearance on Capitol Hill, two members of the Sackler family that controls…
STAT+: Former J&J exec sues for sexual discrimination and harassment, alleging ‘ruthless pattern of retaliation’
A 25-year veteran Johnson & Johnson (JNJ) executive has accused the health care giant of…
STAT+: Pharmalittle: Hospitals grapple with extra dose of Pfizer vaccine; FDA panel meets to review Moderna vaccine
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: AbbVie wins 21 months of wrinkle-free competition for Botox thanks to an ITC ruling
In a victory for AbbVie (ABBV), the U.S. International Trade Commission decided that imports of…
STAT+: Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’
Although the opioid crisis in the U.S. continues to make headlines, a new analysis finds…
STAT+: Pharmalittle: One-quarter of the world won’t have a Covid-19 shot until 2022; naming a Covid vaccine takes time
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
.jpg)
STAT+: Here are the nominees for worst biopharma CEO of 2020
I told my editor that writing the worst CEOs of biopharma column is one of…
One-quarter of the world may not get a Covid-19 vaccine until 2022, experts warn
As wealthy governments race to lock in supplies of Covid-19 vaccines, nearly a quarter of…
STAT+: Pharmalittle: FDA finds Moderna vaccine effective; Trump drug discount card gets new life
Hello, everyone, and how are you today? We are doing just fine, thank you. A…
STAT+: Here are the nominees for best biopharma CEO of 2020
A year like no other requires a new way of drafting a list of Best…
.jpg)
STAT+: State attorneys general urge HHS to penalize drug makers for cutting discounts to hospitals
More than two dozen state attorneys general are urging federal authorities to fine several large…
STAT+: Sackler family members agree to testify at House hearing on Purdue’s role in opioid crisis
In an unexpected development, two members of the Sackler family, which controls Purdue Pharma, will…
STAT+: Pharmalittle: FDA’s Hahn insists Pfizer vaccine was authorized as soon as possible; AstraZeneca to pay $39 billion for Alexion
Good morning, everyone and welcome to another working week. We hope the weekend respite was…
STAT+: Hospital groups sue HHS for failing to stop drug makers from cutting medication discounts
A group of hospital associations filed a lawsuit accusing the Department of Health and Human…
STAT+: World Trade council fails to act on proposal to waive IP rights to Covid-19 drugs and vaccines
In a widely anticipated meeting, a World Trade Organization council failed to act on a…
STAT+: A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea
For the past few weeks, a U.S. bankruptcy court has heard objections to a plan…
STAT+: Pharmalittle: FDA panel endorses Pfizer Covid-19 vaccine; meanwhile, Sanofi shot suffers major setback
And so, another working week will soon draw to a close. Not a moment too…
The timeline for Covid-19 vaccine distribution keeps slipping. Experts say it will change again
When Bruce Lee was helping the U.S. government model delivery plans for H1N1 influenza vaccines,…
Sanofi suffers major setback in development of a Covid-19 vaccine
One of the world’s leading vaccine manufacturers has suffered a major setback in its work…
STAT+: In a petition, Boehringer warns FDA its definition of ‘strength’ threatens biosimilar competition
Arguing the Food and Drug Administration is precluding competition for biosimilar manufacturers, Boehringer Ingelheim has…
STAT+: Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers
In a blow to pharmacy benefit managers, the U.S. Supreme Court ruled that an Arkansas…
STAT+: Pharmalittle: FDA advisers reviewing Pfizer Covid-19 vaccine today; White House hits roadblock on drug discount cards
Hello, everyone, and how are you today? We are doing just fine, thank you. Clear,…
STAT+: Florida finds pharmacy benefit managers are benefiting from a lucrative profit center
As states struggle to control the cost of prescription medicines, a new report found pharmacy…
STAT+: Pharmalittle: AstraZeneca missteps undermined faith in its Covid-19 vaccine; U.S. jockeys with other countries for Pfizer shot
Rise and shine, everyone, another busy day is on the way. In fact, the middle…
STAT+: Federal watchdog urged to investigate the FDA’s handling of Biogen Alzheimer’s drug
A federal watchdog is being asked to investigate the Food and Drug Administration for an…
STAT+: Pharmalittle: FDA staff backs Pfizer Covid-19 vaccine; Trump administration failed to lock in larger vaccine supply
Hello, everyone, and how are you today? We are doing just fine, thank you, now…
STAT+: Families tell U.N. Vertex is violating human rights with cystic fibrosis drug pricing
In an unusual move, a coalition of cystic fibrosis patients and their families have filed…
STAT+: FDA finds fault with a Bristol plant, but it may not upset key approval of a cancer drug
The Food and Drug Administration found problems during a recent inspection of a Bristol Myers…
STAT+: Divergent results from Agios, Forma trials for their sickle cell disease drugs
Two drug makers — Forma Therapeutics and Agios Pharmaceuticals — are each developing their own…
STAT+: Pharmalittle: Biden taps HHS and CDC heads; U.S. taxpayers may get a payback on Gilead’s remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: A payoff for U.S. taxpayers? CDC may have claims on remdesivir patents held by Gilead
Six years ago, a team of scientists at the Centers for Disease Control and Prevention…
STAT+: Constellation’s blood cancer drug shows greater benefit, easing concerns about its future
More patients and an improved response rate might once again shift the sentiment on Constellation…
STAT+: J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
More than three-quarters of the multiple myeloma patients treated with an experimental CAR-T therapy from…
STAT+: Genetically targeted drug from Kura Oncology induces remissions in adult leukemia patients
Kura Oncology presented early clinical trial results Saturday showing for the first time that its…